Enzon Pharmaceuticals, Inc. · Piscataway, NJ United States (NASDAQ: ENZN)
| 20 Kingsbridge Rd. | Phone: 732-980-4500 |
| Piscataway, NJ | |
| 08854 | |
| United States | 
Map This Company |
Enzon Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Cosmetics & Toiletries Wholesalers, Pharmaceutical Preparation MfgCompany Description
Enzon Pharmaceuticals has PEGged its future on researching ways to fight cancer. The company is focused on developing compounds using its PEGylation technology and other platforms to improve the performance and deliverability of existing cancer drugs. PEGylation involves custom attaching polyethylene glycol (PEG) to a drug compound in order to make it more effective and less toxic for patients. Lead candidate PEG-SN38 uses PEGylation to increase exposure of cancer cells to SN38, the active metabolite of a chemotherapy drug marketed as Camptosar in the US.
Enzon Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ENZN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 126 |
Executives
32 executives listed for Enzon Pharmaceuticals, Inc.'s Piscataway, NJ location.
| Chairman | Alexander Denner | |
|---|---|---|
| Vice Chairman | Richard Mulligan | |
| COO and Principal Executive Officer | Ralph del Campo |